// App-Quantinova.ai

2466 : Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Treated with SB2 or Reference Infliximab

Researchers

Presenter

  • Josef S. Smolen

Principal Investigators

  • Jung-Yoon Choe

  • Edward C. Keystone

  • Young Hee Rho

  • Younju Lee

  • Sora Lee

Medical Centers

  • Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria

  • Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea,

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • Samsung Bioepis Co., Ltd., Incheon, Korea, Republic of (South)

Locations

  • Austria

  • Canada

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Interferon

Drug/Treatment

  • Methotrexate

  • Infliximab

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A